发明名称 |
Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors |
摘要 |
This invention provides compositions and methods for treating and vaccinating against an Her2/neu antigen-expressing tumor and inducing an immune response against dominant and several sub-dominant epitopes of the antigen. |
申请公布号 |
US9084747(B2) |
申请公布日期 |
2015.07.21 |
申请号 |
US201012945386 |
申请日期 |
2010.11.12 |
申请人 |
Advaxis, Inc.;The Trustees Of The University Of Pennsylvania |
发明人 |
Shahabi Vafa;Wallecha Anu;Maciag Paulo C.;Paterson Yvonne;Seavey Matthew |
分类号 |
A61K39/02;C12N15/52;C07K14/00;A61K39/00 |
主分类号 |
A61K39/02 |
代理机构 |
Pearl Cohen Zedek Latzer Baratz LLP |
代理人 |
Cohen Mark S.;Pearl Cohen Zedek Latzer Baratz LLP |
主权项 |
1. A recombinant Listeria strain having mutations in the D-alanine racemase (Dal) gene and the D-amino acid transferase (Dat) gene, said recombinant Listeria strain comprising a nucleic acid encoding a first and a second open reading frame, wherein said first open reading frame encodes a recombinant polypeptide comprising SEQ ID NO: 2 fused to a) non-hemolytic LLO protein or N-terminal fragment, b) a PEST sequence, or c) an ActA fragment, and wherein said second open reading frame encodes a metabolic enzyme that complements said mutations, and wherein said recombinant Listeria lacks the ActA virulence gene. |
地址 |
Princeton NJ US |